Docetaxel: a tubulin-stabilizing agent approved for the management of several solid tumors.
about
Tubulin-interactive natural products as anticancer agentsGrb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxelThe quest for a simple bioactive analog of paclitaxel as a potential anticancer agent.Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cyclePretreatment with chemotherapeutics for enhanced nanoparticles accumulation in tumor: the potential role of G2 cycle retention effect.The α7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to taxanes.Docetaxel inhibits the proliferation of non-small-cell lung cancer cells via upregulation of microRNA-7 expression.In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer.Functional p53 determines docetaxel sensitivity in prostate cancer cells.Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors.Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells.Targeting MRP4 expression by anti-androgen treatment reverses MRP4-mediated docetaxel resistance in castration-resistant prostate cancerTRPA1 contributed to the neuropathic pain induced by docetaxel treatment.
P2860
Q24650163-63F50A2F-8B02-4FE4-9941-FEFDA60B36EFQ24658331-15320732-5956-4897-B947-4080CD792AACQ34070252-B63BEADF-6543-4785-A973-8AA8461C4FCDQ36088641-D442F74A-648E-4930-B02C-DEB8499FFA58Q37666715-649F39F5-A917-4C72-91C9-06788FA6F779Q38825012-84CD04DB-DD46-471F-BAED-E606D9EC1EE0Q38828073-38D05703-5AE9-4D3B-8AE4-272FC95C9FA9Q38896408-751A9B47-0C73-4056-B8F9-CD98F5579589Q39274565-C9354213-5C88-49D7-9B4A-C2CA72BABFAFQ39757882-7FC526EC-E702-4BFA-8EB3-17093282AD65Q39997240-20C3E4A1-99EA-4FFA-864B-B61AEC0E3885Q41143231-4CFF2D54-A54F-4D60-824C-156109356761Q48334392-E2345374-758E-438D-ADBB-2B4F66217671
P2860
Docetaxel: a tubulin-stabilizing agent approved for the management of several solid tumors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Docetaxel: a tubulin-stabilizi ...... ement of several solid tumors.
@ast
Docetaxel: a tubulin-stabilizi ...... ement of several solid tumors.
@en
type
label
Docetaxel: a tubulin-stabilizi ...... ement of several solid tumors.
@ast
Docetaxel: a tubulin-stabilizi ...... ement of several solid tumors.
@en
prefLabel
Docetaxel: a tubulin-stabilizi ...... ement of several solid tumors.
@ast
Docetaxel: a tubulin-stabilizi ...... ement of several solid tumors.
@en
P1433
P1476
Docetaxel: a tubulin-stabilizi ...... ement of several solid tumors.
@en
P2093
Bhuvaneswari Ramaswamy
Shannon Puhalla
P304
P356
10.1358/DOT.2006.42.4.968648
P577
2006-04-01T00:00:00Z